Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGender-Affirming CareUnitedHealthcare Gender Dysphoria Coverage | OpenP…
    Ask Trek AI about this page
    CurrentUnitedHealthcarePolicy BIP185.W

    Gender Dysphoria (Gender Identity Disorder) Treatment (for California Only)

    Customize your policy alerts

    Sign up for UnitedHealthcare Policy BIP185.W alerts

    Get alerted when Policy BIP185.W changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Applies to UnitedHealthcare West and California commercial fully insured plans for gender dysphoria treatment and related mental health and substance use disorder benefits.

    Policy Summary
    PayerUnitedHealthcare
    PolicyGender Dysphoria (Gender Identity Disorder) Treatment (for California Only)
    Policy CodePolicy BIP185.W
    Change TypeRegulatory language revisionno material clinical or coverage change
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for medically necessary services before treatment.
    SourceLink
    POLICY UPDATE CHANGES

    Federal/state mandated regulations language pertaining to California Health and Safety Code Sections 1374.72 and 1374.721 was revised.

    CaliforniaGeographic scope
    WPATH 8Clinical criteria basis
    6 monthsAdult surgery hormone period
    12 monthsAdolescent surgery hormone period

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Noncovered categories

    Coverage Criteria

    Medical necessity and utilization review

    Medically necessary treatment is covered when all applicable requirements are met.

    Medical necessity requirements: The service or product addresses the specific needs of the patient and is intended to prevent, diagnose, or treat an illness, injury, condition, or its symptoms, including minimizing progression.
    Standards and appropriateness: The service is provided in accordance with current generally accepted standards of mental health and substance use disorder care and is clinically appropriate in type, frequency, extent, site, and duration.
    Non-convenience requirement: The service is not primarily provided for the economic benefit of the health care service plan and subscribers, or for the convenience of the patient, treating physician, or other health care provider.
    Utilization review criteria: For mental health and substance use disorder services, medical necessity and utilization review criteria are based on current generally accepted standards of care and the most recent treatment criteria and guidelines developed by the nonprofit professional association for the relevant clinical specialty.

    Different, additional, or conflicting criteria may not be applied to care within the scope of those sources.

    Required California benefit categories and access

    Required California mental health and substance use disorder benefits include the following when medically necessary and applicable to the member's contract.

    Covered benefit categories: Coverage includes basic health care services, intermediate services across the full range of levels of care, including residential treatment, partial hospitalization, and intensive outpatient treatment, and prescription drugs when the plan contract includes prescription drug coverage.
    Access and cost-sharing protections: If medically necessary in-network services are unavailable within applicable geographic and timely access standards, the plan must arrange medically necessary out-of-network services and follow-up services, with member cost sharing no greater than for the same covered in-network services.

    Adult hormone treatment

    Adult hormonal treatment may be indicated when ALL of the following are met.

    • Clinical and consent criteria

      • Marked and sustained gender incongruence: Gender incongruence is marked and sustained.
      • Diagnostic criteria: Meets diagnostic criteria for gender incongruence.
      • Capacity to consent: Demonstrates capacity to consent for the specific gender-affirming hormone treatment.
      • Other causes excluded: Other possible causes of apparent gender incongruence have been identified and excluded.

    Adult surgical treatment

    Adult surgical treatment may be indicated when ALL of the following are met.

    • Clinical and consent criteria

      • Marked and sustained gender incongruence: Gender incongruence is marked and sustained.
      • Diagnostic criteria: Meets diagnostic criteria for gender incongruence.
      • Capacity to consent: Demonstrates capacity to consent for the specific gender-affirming surgical intervention.
      • Reproductive counseling: Understands the effect of the surgical intervention on reproduction and has explored reproductive options.

    Detransition or retransition treatment

    For detransition or retransition treatment, the applicable adult criteria above must be met AND all additional criteria below must be met.

    • Comprehensive multidisciplinary assessment: Documentation of a comprehensive multidisciplinary assessment by health care professionals experienced in transgender health.
    • Previous physical changes explored: Concerns with previous physical changes are explored and efforts are made to ensure similar concerns are not replicated by further physical changes.
    • Living in role considered: A recommended period of living in role is considered before further physical changes are recommended.
    • Regret and request stability evaluated: The etiology of regret, if applicable, and the temporal stability of the surgical request are evaluated.

    Adolescent puberty blocking agents

    Adolescent puberty blocking agents may be indicated when ALL of the following are met.

    • Marked and sustained incongruence: Gender diversity or incongruence is marked and sustained over time.
    • Diagnostic criteria: Meets diagnostic criteria for gender incongruence.
    • Consent or assent maturity: Demonstrates the emotional and cognitive maturity required to provide informed consent or assent.
    • Mental health concerns addressed: Mental health concerns that could interfere with diagnostic clarity, capacity to consent, or treatment have been addressed sufficiently for optimal treatment.

    Adolescent hormone treatment

    Adolescent hormonal treatment may be indicated when ALL of the following are met.

    • Marked and sustained incongruence: Gender diversity or incongruence is marked and sustained over time.
    • Diagnostic criteria: Meets diagnostic criteria for gender incongruence.
    • Consent or assent maturity: Demonstrates the emotional and cognitive maturity required to provide informed consent or assent.
    • Mental health concerns addressed: Mental health concerns that could interfere with diagnostic clarity, capacity to consent, or treatment have been addressed sufficiently for optimal treatment.

    Adolescent surgical treatment

    Adolescent surgical treatment may be indicated when ALL of the following are met.

    • Marked and sustained incongruence: Gender diversity or incongruence is marked and sustained over time.
    • Diagnostic criteria: Meets diagnostic criteria for gender incongruence.
    • Consent or assent maturity: Demonstrates the emotional and cognitive maturity required to provide informed consent or assent.
    • Mental health concerns addressed: Mental health concerns that could interfere with diagnostic clarity, capacity to consent, or treatment have been addressed sufficiently for optimal treatment.

    Covered gender-affirming services

    When the applicable adult or adolescent criteria are met, the following services are covered.

    • Covered service categories

      • Hormone treatments listed in WPATH Version 8, Appendix C.
      • Surgical and reconstructive procedures listed in WPATH Version 8, Appendix E.
      • Puberty blockers: Clinically indicated puberty blocking agents per WPATH.
      • Voice services: Voice lessons and/or voice therapy, with or without surgery.

    The cited California mental health and substance use disorder coverage requirements do not apply to contracts entered into between the State Department of Health Care Services and a health care service plan for enrolled Medi-Cal beneficiaries.

    Drugs for hair loss are not covered under this policy.

    Drugs for sexual performance are not covered for members who have undergone genital reconstruction.

    Drugs or devices not approved by the FDA for use in the United States are not covered.

    A service is not medically necessary when it is not directed to the patient's specific condition or symptoms, is inconsistent with generally accepted standards of care, is not clinically appropriate in type, frequency, extent, site, or duration, or is provided primarily for the economic benefit of the plan or for the convenience of the patient or provider.

    Clinical Thresholds and Review Standards

    Adult surgical hormone stability
    Required durationAt least 6 months of hormone treatment
    Extended durationLonger if required to achieve the desired surgical result
    ExceptionHormone therapy is not required when it is not desired or is medically contraindicated
    Adolescent puberty or hormone treatment developmental stage
    Developmental requirementHas reached Tanner stage 2
    Applies toPuberty blocking agents for gender dysphoria
    Also applies to

    Provider Requirements and Denial Risks

    Prior Authorization

    Prior Authorization Required

    Obtain prior authorization for medically necessary gender dysphoria services from UnitedHealthcare or a provider delegated by UnitedHealthcare, as applicable, before services are rendered.

    Note

    Use Current WPATH Criteria

    Apply the most recent WPATH Standards of Care and related criteria and guidelines when assessing and documenting treatment for gender dysphoria. California utilization review must use the current WPATH criteria for medically necessary treatment.

    Documentation Required

    Adult Assessment Documentation

    Policy Background

    This policy addresses treatment for gender dysphoria within California-regulated commercial health plan coverage. California law requires medically necessary mental health and substance use disorder treatment to be covered under the same terms and conditions applied to other medical conditions. Depending on the member's contract, required coverage may include basic health care services, intermediate levels of care, and prescription drugs. When medically necessary in-network services are not available within applicable geographic and timely access standards, the plan must arrange medically necessary out-of-network services with no greater member cost sharing than would apply to the same covered in-network services.

    Definitions and Review Terms

    Medically necessary treatment of a mental health or substance use disorder
    What it addressesThe specific needs of the patient
    PurposeTo prevent, diagnose, or treat an illness, injury, condition, or its symptoms, including minimizing progression
    Clinical standardConsistent with generally accepted standards of mental health and substance use disorder care and clinically appropriate in type, frequency, extent, site, and duration
    Excluded purposesNot primarily for the economic benefit of the health care service plan or subscribers, or for the convenience of the patient, treating physician, or other health care provider
    Generally accepted standards of mental health and substance use disorder care
    DefinitionStandards of care and clinical practice generally recognized by health care providers practicing in relevant clinical specialties
    Policy Summary
    PayerUnitedHealthcare
    PolicyGender Dysphoria (Gender Identity Disorder) Treatment (for California Only)
    Policy CodePolicy BIP185.W
    Change TypeRegulatory language revisionno material clinical or coverage change
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for medically necessary services before treatment.
    SourceLink
    On This Page
    Coverage CriteriaClinical Thresholds and Review StandardsProvider Requirements and Denial RisksPolicy BackgroundDefinitions and Review Terms
  1. Health conditions assessed: Mental health and physical conditions that could negatively impact treatment have been assessed, with risks and benefits discussed.
  2. Reproductive counseling: Understands the effect of treatment on reproduction and has explored reproductive options.
  3. Other causes excluded: Other possible causes of apparent gender incongruence have been identified and excluded.
  4. Health conditions assessed: Mental health and physical conditions that could negatively impact surgery have been assessed, with risks and benefits discussed.
  5. Hormone stability when indicated: Is stable on the gender-affirming hormone regimen when indicated for the planned procedure.At least 6 months, or longer if required to achieve the desired surgical result

    Not required when hormone therapy is not desired or is medically contraindicated.

  6. Reproductive counseling: Is informed of reproductive effects, including potential loss of fertility, and available fertility-preservation options.
  7. Pubertal development: Has reached Tanner stage 2.Tanner stage 2
  8. Reproductive counseling: Is informed of reproductive effects, including potential loss of fertility, and available fertility-preservation options.
  9. Pubertal development: Has reached Tanner stage 2.Tanner stage 2
  10. Reproductive counseling: Is informed of reproductive effects, including potential loss of fertility, and available fertility-preservation options.
  11. Hormone treatment duration: Has received gender-affirming hormone therapy for the required period for specified gender-affirming procedures.At least 12 months, or longer if required to achieve the desired surgical result

    Applies to breast augmentation, orchiectomy, vaginoplasty, hysterectomy, phalloplasty, metoidioplasty, and facial surgery unless hormone therapy is not desired or is medically contraindicated.

  12. Adolescent hormonal treatment for gender dysphoria
    Adolescent surgical hormone treatment
    Required durationAt least 12 months of gender-affirming hormone therapy
    Extended durationLonger if required to achieve the desired surgical result
    ExceptionHormone therapy is not required when it is not desired or is medically contraindicated
    Specified proceduresBreast augmentation, orchiectomy, vaginoplasty, hysterectomy, phalloplasty, metoidioplasty, and facial surgery as part of gender-affirming treatment
    Interrater reliability pass rate
    Minimum pass rateAt least 90 percent
    If threshold is not metImmediately provide remediation of poor interrater reliability
    New staff testingProvide interrater reliability testing for all new staff before they conduct utilization review without supervision

    For adult hormone or surgical treatment, submit an assessment by a health care professional competent in assessing transgender people. The documentation must establish the applicable gender-incongruence, consent capacity, exclusion of other causes, relevant mental and physical health assessment, reproductive counseling, and any treatment-specific requirements.

    • Hormone treatment: document marked and sustained gender incongruence, diagnostic criteria, capacity to consent, assessment of conditions that could affect treatment, discussion of risks and benefits, and exploration of reproductive options.
    • Surgical treatment: also document capacity to consent to the specific procedure and stability on gender-affirming hormones when indicated, subject to the applicable exception when hormones are not desired or are medically contraindicated.
    Documentation Required

    Detransition or Ret retransition Assessment

    For hormone or surgical treatment sought for detransition or retransition, document a comprehensive multidisciplinary assessment by professionals experienced in transgender health, in addition to the applicable adult criteria.

    • Explore concerns about prior physical changes and efforts to avoid replicating those concerns through further physical changes.
    • Document a recommended period of living in role before further physical changes are recommended.
    • Evaluate the etiology of regret, when applicable, and the temporal stability of the surgical request.
    Documentation Required

    Adolescent Multidisciplinary Documentation

    For adolescent puberty blockers, hormone treatment, or surgery, submit documentation from a multidisciplinary team that includes both medical and mental health professionals competent in transgender assessment and reflects the team’s assessment and opinion.

    • Document marked and sustained gender diversity or incongruence, diagnostic criteria, emotional and cognitive maturity for informed consent or assent, and relevant mental health concerns addressed sufficiently for treatment.
    • Document counseling about reproductive effects, including potential loss of fertility and fertility-preservation options; puberty blockers and hormones also require Tanner stage 2.
    • For adolescent surgery, document at least 12 months of gender-affirming hormone therapy, or a longer period if needed for the desired surgical result, unless hormones are not desired or are medically contraindicated.
    Denial Risk

    Medical Necessity and Clinical Appropriateness

    Services must meet medical-necessity and clinical-appropriateness requirements: they must address the patient’s specific condition or symptoms, follow generally accepted standards of mental health and substance use disorder care, and be appropriate in type, frequency, extent, site, and duration. Services may be denied when they are primarily for plan or subscriber economic benefit or for patient or provider convenience.

    • Base medical-necessity and utilization-review determinations on current generally accepted standards of care.
    • Do not submit services that are clinically inappropriate, outside the applicable standards, or primarily intended for economic benefit or convenience.
    Denial Risk

    Applicable Clinical Criteria Must Be Met

    Coverage may be denied when applicable WPATH-based adult or adolescent criteria are not met or are not adequately documented. Ensure the record supports every criterion applicable to the requested hormone, puberty-blocking, or surgical treatment.

    • Adult requests require the applicable assessment, diagnostic, consent, exclusion, health-risk, and reproductive-counseling documentation.
    • Adolescent requests require multidisciplinary medical and mental health assessment and opinion, with treatment-specific maturity, mental health, reproductive, Tanner-stage, and hormone-therapy documentation as applicable.
    Denial Risk

    Required Hormone-Treatment Period

    Surgical treatment may be denied when the required period of gender-affirming hormone treatment or regimen stability is absent and no applicable exception is documented.

    • Adults: document stability on the hormone regimen when indicated, which may include at least 6 months or a longer period needed to achieve the desired surgical result.
    • Adolescents: document at least 12 months of gender-affirming hormone therapy, or longer when required for the desired surgical result.
    • An exception applies when hormone therapy is not desired or is medically contraindicated; document the applicable reason.
    Billing Rule

    Explicitly Noncovered Items

    Do not submit claims for items expressly excluded from coverage under this policy.

    • Drugs for hair loss.
    • Drugs for sexual performance for members who have undergone genital reconstruction.
    • Drugs or devices not approved by the FDA for use in the United States.
    Evidence sourcesPeer-reviewed scientific studies and medical literature
    Clinical guidance sourcesClinical practice guidelines and recommendations of nonprofit health care provider professional associations, specialty societies, and federal government agencies
    Medication sourceDrug labeling approved by the United States Food and Drug Administration
    Utilization review
    ProcessReviewing covered health care services and benefits
    Primary determinationDetermining medical necessity
    Included functionsCertification of care, denial of care, and support of the appeals process
    Generally accepted standards of mental health and substance use disorder care
    DefinitionStandards of care and clinical practice generally recognized by providers in relevant clinical specialties
    Scientific evidencePeer-reviewed scientific studies and medical literature
    Professional and governmental guidanceClinical practice guidelines and recommendations from professional associations, specialty societies, and federal agencies
    Medication sourceDrug labeling approved by the United States Food and Drug Administration
    Utilization review
    Review timingProspective, retrospective, or concurrent
    Possible decisionsApproval, modification, delay, or denial of requests for health care service coverage
    Review basisBased in whole or in part on medical necessity
    Evaluation factorsMedical necessity, appropriateness, level of care, service intensity, efficacy, or efficiency
    Utilization review criteria
    DefinitionCriteria, standards, protocols, or guidelines
    Used byA health care service plan
    PurposeTo conduct utilization review